TNSN06454A1 - Treatment of cancer - Google Patents

Treatment of cancer

Info

Publication number
TNSN06454A1
TNSN06454A1 TNP2006000454A TNSN06454A TNSN06454A1 TN SN06454 A1 TNSN06454 A1 TN SN06454A1 TN P2006000454 A TNP2006000454 A TN P2006000454A TN SN06454 A TNSN06454 A TN SN06454A TN SN06454 A1 TNSN06454 A1 TN SN06454A1
Authority
TN
Tunisia
Prior art keywords
cancer
treatment
leukaemia
preparations
relates
Prior art date
Application number
TNP2006000454A
Other languages
French (fr)
Inventor
Tracey Carter
James Peter Burnie
Ruth Christine Matthews
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2005/002545 external-priority patent/WO2006003384A1/en
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Publication of TNSN06454A1 publication Critical patent/TNSN06454A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to a novel medicaments and preparations comprising effective anti-cancer agents together with an anti-Hsp90 antibody which together provide an enhanced efficacy in the treatment of cancer, and leukaemia.
TNP2006000454A 2004-07-02 2006-12-29 Treatment of cancer TNSN06454A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0414885A GB0414885D0 (en) 2004-07-02 2004-07-02 Cancer therapy
PCT/GB2005/002545 WO2006003384A1 (en) 2004-07-02 2005-06-30 Treatment of cancer

Publications (1)

Publication Number Publication Date
TNSN06454A1 true TNSN06454A1 (en) 2008-02-22

Family

ID=32843486

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000454A TNSN06454A1 (en) 2004-07-02 2006-12-29 Treatment of cancer

Country Status (3)

Country Link
GB (1) GB0414885D0 (en)
TN (1) TNSN06454A1 (en)
ZA (1) ZA200700845B (en)

Also Published As

Publication number Publication date
GB0414885D0 (en) 2004-08-04
ZA200700845B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
UA105210C2 (en) Anti-cancer vaccine and use thereof
HK1119071A1 (en) Combinations of therapeutic agents
FR2869231B1 (en) THERAPEUTIC COMPOSITION CONTAINING AT LEAST ONE PYRROLOBENZODIAZEPINE DERIVATIVE AND FLUDARABINE
CA115590S (en) Back therapy device
EA200602047A1 (en) SULPHONYLETHYL PHOSPHORODYAMIDATES, INTENDED FOR USE IN CANCER TREATMENT
NO20070580L (en) Treatment of cancer.
IL184617A0 (en) Dr5 antibodies and uses thereof
TW200642682A (en) A combination of medical drugs to augment the anti-cancer effect of chemotherapy
CA119221S (en) Blister package
EP1851244A4 (en) An anti-cd137 antibody as an agent in the treatement of cancer and glycosylation variants thereof
WO2006041641A3 (en) Therapeutic agents with decreased toxicity
HK1080447B (en) Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
CY1110329T1 (en) PEGylated Liposomal Doxorubicin in Combination with Ectein Succinin 743
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
MX2008001597A (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment.
EA200701172A1 (en) 2-ALKOXI-3,4,5-TRIHYDROXIALKYLAMIDES, THEIR RECEIVING, COMPOSITIONS, THEIR CONTAINING, AND APPLICATION
LU92202I9 (en)
UA99601C2 (en) Use of an anti-cd151 antibody in the treatment of cancer
HK1076055A1 (en) Covalent conjugates between artemisinin-related endoperoxides and iron- carrying proteins and methods of use
EP1503748A4 (en) Drugs for mitigating taxane-induced neurotoxicity
EA200970353A1 (en) COMBINED MEDICINE
PT1713438E (en) Medicinal soap
SI1869185T1 (en) Conjugate comprising p21 protein for the treatment of cancer
GB0111628D0 (en) Binding member